Internal Medicine, Nephrology · Cincinnati, OH
NPI
1730685603
Since 2018
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3200 Burnet Ave
Cincinnati, OH, 45229
Phone (513) 584-7001
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
720 services
Medicare patients, 2024
215
Average age 70
Drug cost, 2024
$203K
916 prescriptions
Company payments, 2025
$140
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory M McGraw was code 99233 (hospital e&m - subsequent), 143 times for 54 patients. In total Gregory M McGraw billed 720 services in 19 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 143 | 54 | $89.75 | $13K |
| 99214 Office E&M - Established | Facility | 139 | 68 | $65.67 | $9,128 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 132 | 70 | $12.30 | $1,623 |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 29 | $59.66 | $2,386 |
| 90945 Peritoneal Dialysis | Facility | 38 | 16 | $64.14 | $2,437 |
| 99214 Office E&M - Established | Office | 36 | 28 | $94.95 | $3,418 |
| 90960 ESRD Related Services (not dialysis) | Office | 35 | 13 | $263.48 | $9,222 |
| 90935 Hemodialysis | Facility | 32 | 20 | $53.65 | $1,717 |
| 99223 Hospital E&M - Initial | Facility | 28 | 27 | $130.92 | $3,666 |
| 90961 ESRD Related Services (not dialysis) | Office | 21 | 14 | $208.45 | $4,378 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 16 | $12.23 | $232 |
| 99204 Office E&M - New | Facility | 18 | 18 | $80.54 | $1,450 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $98.87 | $1,088 |
By year: 2023 $13K for 163 services; 2024 $57K for 720 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory M McGraw prescribed most often to Medicare patients was Amlodipine Besylate, with 84 prescriptions and refills. In total Gregory M McGraw wrote 916 Medicare prescriptions that cost $203K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 84 | 213 | 30 | $492 |
| Prosol Parenteral Amino Acid 20% No.1 | 76 | 76 | Under 11 | $13K |
| Torsemide Generic | 73 | 154 | 26 | $1,361 |
| Furosemide Generic | 60 | 130 | 19 | $250 |
| Nifedipine Er Nifedipine | 56 | 133 | 17 | $2,282 |
| Spironolactone Generic | 52 | 135 | 17 | $579 |
| Losartan Potassium Generic | 42 | 125 | 17 | $301 |
| Calcitriol Generic | 41 | 75 | Under 11 | $597 |
| Lisinopril Generic | 36 | 106 | 15 | $225 |
| Carvedilol Generic | 29 | 68 | 12 | $207 |
| Allopurinol Generic | 20 | 55 | Under 11 | $168 |
| Calcium Acetate Generic | 19 | 21 | Under 11 | $289 |
| Hydrochlorothiazide Generic | 17 | 49 | Under 11 | $22.38 |
| Tamsulosin Hcl Generic | 17 | 42 | Under 11 | $101 |
| Sodium Citrate-Citric Acid Citric Acid/Sodium Citrate | 16 | 16 | Under 11 | $436 |
Brand drugs: 161 claims; generic drugs: 739 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory M McGraw $140 ($140 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $140.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.